about
Notch signaling maintains neural rosette polarityGenetic interaction between Lrp6 and Wnt5a during mouse developmentWnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivoAlpha-chemokines regulate proliferation, neurogenesis, and dopaminergic differentiation of ventral midbrain precursors and neurospheresSFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cellsWnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cellsThe extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivoDelayed dopaminergic neuron differentiation in Lrp6 mutant miceNotch signaling: simplicity in design, versatility in function.Therapeutic modulation of Notch signalling--are we there yet?The developmental biology of genetic Notch disorders.Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ.Notch induces cyclin-D1-dependent proliferation during a specific temporal window of neural differentiation in ES cells.p57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neural stem cells.Differential involvement of caveolin-1 in brown adipocyte signaling: impaired beta3-adrenergic, but unaffected LPA, PDGF and EGF receptor signaling.Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.Do as I say, Not(ch) as I do: Lateral control of cell fate.Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/beta-catenin and protein kinase Calpha.Cholangiopathies - Towards a molecular understandingCalcium Signaling in Liver Injury and RegenerationCorrigendum to "Cholangiopathies - Towards a molecular understanding" [EBioMedicine 35 (2018) 381-393]Control of Notch-ligand endocytosis by ligand-receptor interactionRegenerative medicine: a 2009 overviewEditorial: Signaling pathways instruct the blueprint of lifeMouse Models for Diseases in the Cholangiocyte Lineage
P50
Q27321532-14E739D6-89D4-46E5-93D9-75813B372249Q28510904-D2FB72A3-12B8-4C2D-858E-261BB7A968EAQ28513819-64BAC170-2442-4F6E-AAB3-0A00DFA08F7BQ28568981-6C4C9F5D-187B-4E77-8E98-62F2B396A3C0Q28585649-356B879D-D1FA-4C59-95F9-A8173A50F643Q28587554-FCE990C2-8BE9-4E84-8B7E-7A50A77B1673Q28588070-4EC66490-9104-4822-9DCC-8AEA505ED6D3Q28594108-03195878-7FB3-4F40-B394-C729DCF31272Q37914480-5C74A7E6-37D7-4DA0-B6F6-3B219F6672B8Q38208211-764842DC-2196-4364-B1D3-4E1B5EB1CA1AQ38781884-5D467BFD-0C78-4D29-90F2-62FB8477B488Q39239566-CDEE7FA7-4C44-4E83-A408-B5FB315C60D9Q39649080-0FDCA0F8-1EC0-4509-A29F-A73E19076680Q39826816-84034C55-E88E-45EE-A5A3-FF97B14D1D04Q43104238-52243DAB-B797-47BF-9891-D8453EB91F4BQ46256873-BCECC1D8-8BCE-4074-9207-454551795051Q50426445-D381B65B-E466-4576-B877-804F149FF2FFQ51944311-46B34A19-B423-4E79-A90D-9A66C22278CDQ57109524-88C843D3-3AE4-41B4-B68F-95377492D485Q57115313-4EA4F4AC-9358-41B5-AAC0-9821B60A3022Q57479919-8A312A02-8FA4-4A18-A160-3C1C48382510Q63488065-3B6B9440-6DC7-451E-861E-D22B2F3CE579Q84572912-A26F287D-180A-41F4-BE32-A0A5CB9B3A81Q89048903-7ECEEAC4-0F87-4975-A1B4-839A25850EAAQ90260828-6F162870-3E55-49B3-A496-12312D390470
P50
description
Zweeds onderzoekster
@nl
researcher ORCID ID = 0000-0002-8608-625X
@en
name
Emma R Andersson
@ast
Emma R Andersson
@en
Emma R Andersson
@es
Emma R Andersson
@ga
Emma R Andersson
@nl
Emma R Andersson
@sl
Emma R Andersson
@sq
type
label
Emma R Andersson
@ast
Emma R Andersson
@en
Emma R Andersson
@es
Emma R Andersson
@ga
Emma R Andersson
@nl
Emma R Andersson
@sl
Emma R Andersson
@sq
prefLabel
Emma R Andersson
@ast
Emma R Andersson
@en
Emma R Andersson
@es
Emma R Andersson
@ga
Emma R Andersson
@nl
Emma R Andersson
@sl
Emma R Andersson
@sq
P106
P1153
25629404300
P21
P27
P31
P496
0000-0002-8608-625X